QIM
TXMD icon

Quantitative Investment Management’s TherapeuticsMD TXMD Stock Holding History

Quantitative Investment Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,824
Closed -$1.19M – 879
2018
Q2 		$1.19M Buy
+3,824
New +$1.17M 0.02% 456
2017
Q2 		– Sell
-5,552
Closed -$2M – 896
2017
Q1 		$2M Buy
+5,552
New +$1.72M 0.03% 478
2016
Q3 		– Sell
-1,032
Closed -$438K – 872
2016
Q2 		$438K Buy
+1,032
New +$425K 0.02% 569

Other funds holding TXMD

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Quantitative Investment Management's TXMD Position: Q3 2018 in Review

Quantitative Investment Management sold out of TherapeuticsMD (TXMD) in Q3 2018, closing a stake of 3,824 shares — an estimated $1.19M sold.

Quantitative Investment Management first reported a position in TXMD in Q2 2016 and held it in 3 quarters. The position peaked at $2M in Q1 2017. 155 funds tracked by Wall St. Rank hold TXMD as of Q3 2018.

  • Quantitative Investment Management reported no remaining TherapeuticsMD position as of Q3 2018 after selling out during the quarter.
  • Quantitative Investment Management sold 3,824 TherapeuticsMD shares in Q3 2018, an estimated $1.19M.
  • Quantitative Investment Management first reported a position in TherapeuticsMD in Q2 2016 and held it in 3 quarters.
  • Quantitative Investment Management's TherapeuticsMD position peaked at $2M in Q1 2017.
  • 155 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2018.

Based on Quantitative Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.